Fiscal period | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
Period End Date | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 |
Revenue | -- | -- | -- | -- | -- | 1,029.52 | 962.07 | 811.11 | 762.42 | 685.17 |
Service revenue | 110.99 | 104.38 | 100.39 | 123.46 | 115.26 | -- | -- | -- | -- | -- |
MAS | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Classic Fusion | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Product revenue | 1,090.95 | 1,034.61 | 950.19 | 1,044.61 | 986.46 | -- | -- | -- | -- | -- |
Total Revenues | 1,201.94 | 1,138.99 | 1,050.58 | 1,168.07 | 1,101.71 | 1,029.52 | 962.07 | 811.11 | 762.42 | 685.17 |
Cost of Products Sold | 251.77 | 245.57 | 247.81 | 232.47 | 234.51 | -- | -- | -- | -- | -- |
Cost of goods sold | -- | -- | -- | -- | -- | 269.01 | 240.09 | 194.48 | 182.36 | 180.48 |
Cost of services | 84.74 | 76.71 | 73.82 | 79.88 | 76.65 | -- | -- | -- | -- | -- |
Gross Profit | 865.44 | 816.71 | 728.95 | 855.71 | 790.56 | 760.51 | 721.98 | 616.63 | 580.06 | 504.69 |
Amortization of intangible assets | 49.38 | 57.31 | 51.73 | 51.10 | 50.67 | 48.04 | 42.00 | 12.52 | 13.57 | 19.33 |
Intangible asset impairment charge | -- | -- | -- | -- | -- | -- | -- | 0.00 | 10.71 | 0.00 |
Research and development | 98.52 | 92.63 | 79.84 | 72.38 | 61.70 | 50.43 | 48.00 | 35.85 | 37.99 | 32.21 |
NeoDisc technology costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
In-process research and development | -- | -- | -- | -- | 8.91 | -- | -- | -- | -- | -- |
Stock-based compensation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
General and Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Selling, general and administrative | 634.10 | 610.09 | 547.20 | 611.18 | 575.84 | 539.91 | 533.62 | 464.53 | 469.65 | 420.06 |
Litigation award | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 |
Litigation liability | -- | -- | -- | -- | (27.80) | (4.50) | 43.31 | 41.83 | (30.00) | -- |
Business transition costs | 4.98 | (68.72) | (10.88) | 2.00 | (11.47) | (4.29) | (18.14) | (6.48) | -- | -- |
Purchase of in-process research and development | -- | -- | (1.01) | -- | -- | -- | -- | -- | -- | -- |
Total Operating Expenses | 777.02 | 828.74 | 690.65 | 732.66 | 736.39 | 647.16 | 598.45 | 477.55 | 561.91 | 471.60 |
Interest expense | 17.42 | 21.06 | 70.47 | 38.53 | 37.86 | 38.02 | 40.52 | 29.08 | 27.91 | 27.18 |
Interest and other income, net | 2.76 | 0.16 | 1.47 | 1.92 | 0.59 | 0.44 | 1.09 | 1.59 | 0.97 | 0.76 |
Other income (expense), net | (21.43) | (25.46) | (16.85) | (5.93) | (8.17) | (1.54) | (0.31) | 0.43 | (2.41) | 3.10 |
Loss on repurchase of convertible notes | -- | -- | -- | -- | -- | -- | (19.09) | -- | -- | -- |
Income (loss) before income taxes | 52.32 | (58.38) | (47.55) | 80.52 | 8.72 | 74.23 | 64.71 | 112.02 | (11.21) | 9.77 |
Income tax expense (benefit) | 11.92 | 5.70 | (10.39) | 15.28 | (3.76) | (7.04) | 29.28 | 46.73 | 6.29 | 2.78 |
Current : Federal | 26.13 | 3.61 | (0.04) | 4.80 | (4.19) | 5.97 | -- | 1.48 | 32.39 | 10.48 |
Deferred : Federal | (17.43) | (0.90) | (13.80) | 5.87 | (5.94) | (0.91) | -- | 42.72 | (28.10) | (8.06) |
Deferred : State | (6.13) | (6.57) | (8.32) | (4.57) | (7.09) | (4.22) | -- | 4.43 | (2.28) | (0.91) |
Current : Foreign | 1.60 | 3.27 | 4.68 | 2.21 | 5.97 | 2.79 | -- | 2.09 | 2.26 | 0.92 |
Current : State | 4.68 | 2.99 | 2.31 | 4.64 | 2.04 | 0.78 | -- | 0.18 | 3.36 | 2.72 |
Deferred : Foreign | (1.79) | (23.04) | (3.85) | (0.82) | (98.80) | (2.22) | -- | (0.70) | (1.34) | (2.38) |
Changes in valuation allowance | 5.16 | 26.31 | 9.20 | 2.54 | 103.99 | -- | -- | -- | -- | -- |
Changes in tax rate | (0.30) | 0.05 | (0.58) | 0.61 | 0.26 | -- | -- | -- | -- | -- |
Consolidated Net Income (loss) | 40.41 | (64.09) | (37.15) | 65.23 | 12.48 | 81.26 | 35.43 | 65.29 | (17.50) | 6.99 |
Net loss attributable to noncontrolling interests | -- | -- | -- | 0.00 | -- | (1.74) | (1.72) | (1.00) | (0.78) | (0.92) |
Net Income (loss) Available to Common Shareholders | 40.41 | (64.09) | (37.15) | 65.23 | 12.48 | 83.01 | 37.15 | 66.29 | (16.72) | 7.90 |
Net Income (loss) Available to Common Shareholders (Diluted) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Net Earnings Per Share (Basic) | 0.78 | (1.24) | (0.72) | 1.26 | 0.24 | 1.63 | 0.74 | 1.36 | (0.36) | 0.18 |
Net Earnings Per Share (Diluted) | 0.76 | (1.24) | (0.72) | 1.23 | 0.24 | 1.50 | 0.69 | 1.26 | (0.36) | 0.17 |
Weighted Average Shares Outstanding (Basic) | 52.01 | 51.59 | 51.42 | 51.96 | 51.38 | 50.87 | 50.08 | 48.69 | 46.72 | 44.46 |
Weighted Average Shares Outstanding (Diluted) | 57.36 | 51.59 | 51.42 | 53.16 | 52.36 | 55.19 | 54.10 | 52.42 | 46.72 | 46.79 |